CompletedPhase 3NCT03401060

Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis

Studying Mastocytosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Assistance Publique - Hôpitaux de Paris
Principal Investigator: Olivier Hermine, MD
Assistance Publique - Hôpitaux de Paris
Intervention: Denosumab(drug)
Enrollment: 24 enrolled
Eligibility: 18 years · All sexes
Timeline: 2018 – 2024

Study locations (11)

Jean Minjoz Hospital, Dermatology department, Besançon, France
Caen Hospital, Clinical haematology department, Caen, France
Estaing Hospital, Cellular therapy and clinical haematology department, Clermont-Ferrand, France
Lille CHRU Hospital, Internal medicine and clinical immunology department, Lille, France
La Timone Hospital, Dermatology and cutaneous oncology department, Marseille, France
Lapeyronie Hospital, Rheumatology and Immunology department, Montpellier, France
La Pitié-Salpêtrière Hospital, Internal medicine and clinical immunology department, Paris, France
Cochin Hospital, Rheumatology department, Paris, France
Necker Hospital, Adult haematology department, Paris, France
Strasbourg Hospital, Rheumatology department, Strasbourg, France
Toulouse Hospital, Dermatology department, Toulouse, France

Collaborators

CEREMAST · URC-CIC Paris Descartes Necker Cochin

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03401060 on ClinicalTrials.gov

Other trials for Mastocytosis

Additional recruiting or active studies for the same condition.

See all trials for Mastocytosis →

← Back to all trials